2024 annual financial data
Tango Therapeutics 2024 Net margin
Direct answer
Net margin was -309.73%.
Operating income was -145,595,000 USD and net income was -130,302,000 USD.
Operating cash flow was -131,501,000 USD.
Get free Tango Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,069,000 USD
- Operating income
- -145,595,000 USD
- Net income
- -130,302,000 USD
- Operating cash flow
- -131,501,000 USD